Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
Inari Medical, Inc. (NARI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/16/2023 |
144/A
| Form 144/A - Report of proposed sale of securities: [Amend] |
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/02/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/02/2023 |
8-K
| Quarterly results |
| 07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/31/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/19/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/03/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/06/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/06/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/06/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 02/27/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 02/27/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/27/2023 |
8-K
| Quarterly results|
Docs:
|
"Consolidated Statements of Operations and Comprehensive Income Three Months Ended December 31, Years Ended December 31, 2022 2021 2022 2021 Revenue $ 107,771 $ 83,218 $ 383,471 $ 276,984 Cost of goods sold 13,128 8,280 44,506 24,757 Gross profit 94,643 74,938 338,965 252,227 Operating expenses Research and development 20,412 18,726 74,221 51,018 Selling, general and administrative 80,122 54,466 292,843 190,365 Total operating expenses 100,534 73,192 367,064 241,383 income from operations 1,746 10,844 Other income Interest income 970 24 1,852 154 Interest expense Change in fair value of warrant liabilities — — — — Other income 187 356 Total other income 1,083 1,914 income before income taxes 1,681 10,685 Provision for income taxes 990 574 3,082 845 Net income $ $ 1,107 $ $ 9,840 Other c..." |
|
| 02/14/2023 |
SC 13G/A
| MACQUARIE GROUP LTD reports a 3.4% stake in Inari Medical Inc. |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 8.1% stake in Inari Medical Inc. |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/27/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"GENERAL RELEASE 1. Release. For valuable consideration, the receipt and adequacy of which are hereby acknowledged, the undersigned does hereby release and forever discharge the “Releasees” hereunder, consisting of Inari Medical, Inc., a Delaware corporation , and the Company’s partners, subsidiaries, associates, affiliates, successors, heirs, assigns, agents, directors, officers, employees, representatives, lawyers, insurers, and all persons acting by, through, under or in concert with them, or any of them, of and from any and all manner of action or actions, cause or causes of action, in law or in equity, suits, debts, liens, contracts, agreements, promises, liability, claims, demands, damages, losses, costs, attorneys’ fees or expenses, of any nature whatsoever, known or un..." |
|
| 01/26/2023 |
SC 13G/A
| BlackRock Inc. reports a 10.6% stake in INARI MEDICAL, INC |
| 01/10/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
|
|
|